The Claim
In a modeled population of overweight or obese adults with preexisting cardiovascular disease and no diabetes, medication efficacy on mortality and medication cost are the two most influential factors determining the cost-effectiveness of semaglutide.
What the research says
Not yet evaluated
We are still looking at what the research says.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
For people who are overweight or obese, have heart disease but not diabetes, the biggest things that decide whether semaglutide is worth the cost are how well it prevents death and how much the drug itself costs.
See the scientific wording
Medication efficacy on mortality and medication cost are the two factors with the greatest influence on the cost-effectiveness of semaglutide in a modeled population of overweight or obese adults with preexisting cardiovascular disease and no diabetes.
What the research says
1 studyStudy: Cost-Effectiveness of Semaglutide in Patients With Obesity and Cardiovascular Disease.
The study looked at how well semaglutide works and how much it costs, and found those two things matter most in deciding if it’s worth the money for patients with heart disease and obesity.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.